These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28425256)

  • 21. Antenatal exposure to Ureaplasma species exacerbates bronchopulmonary dysplasia synergistically with subsequent prolonged mechanical ventilation in preterm infants.
    Inatomi T; Oue S; Ogihara T; Hira S; Hasegawa M; Yamaoka S; Yasui M; Tamai H
    Pediatr Res; 2012 Mar; 71(3):267-73. PubMed ID: 22258085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular function indices and platelet parameters for early prediction value of bronchopulmonary dysplasia: a retrospective study.
    Li T; Xia B; Liang S; He Q; Zhang S; Chen X; Xu N
    BMC Pediatr; 2024 Jun; 24(1):391. PubMed ID: 38862972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of SNAP to perinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants.
    Li Y; Yan J; Li M; Xiao Z; Zhu X; Pan J; Li X; Feng X
    BMC Pediatr; 2013 Sep; 13():138. PubMed ID: 24020335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm.
    Cuna A; Liu C; Govindarajan S; Queen M; Dai H; Truog WE
    J Pediatr; 2018 Jun; 197():23-28.e2. PubMed ID: 29551313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers in cord blood for prediction of bronchopulmonary dysplasia in premature infants.
    Tian XY; Zhang XD; Li QL; Shen Y; Zheng J
    Clin Exp Obstet Gynecol; 2014; 41(3):313-8. PubMed ID: 24992784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Proendothelin-1 as an Early Marker of Bronchopulmonary Dysplasia.
    Baumann P; Fouzas S; Pramana I; Grass B; Niesse O; Bührer C; Spanaus K; Wellmann S
    Neonatology; 2015; 108(4):293-6. PubMed ID: 26355291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA expression aberration associated with bronchopulmonary dysplasia in preterm infants: a preliminary study.
    Wu YT; Chen WJ; Hsieh WS; Tsao PN; Yu SL; Lai CY; Lee WC; Jeng SF
    Respir Care; 2013 Sep; 58(9):1527-35. PubMed ID: 23481439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review.
    Zhang ZQ; Huang XM; Lu H
    Eur J Pediatr; 2014 Jan; 173(1):15-23. PubMed ID: 23996017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.
    Zachman RD; Samuels DP; Brand JM; Winston JF; Pi JT
    Am J Clin Nutr; 1996 Jan; 63(1):123-9. PubMed ID: 8604659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study.
    Li H; Huang Z; Yang C; Han D; Wang X; Qiu X; Zhang Z; Chen X
    Pediatr Pulmonol; 2023 Dec; 58(12):3516-3522. PubMed ID: 37712600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
    Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
    Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia.
    Procianoy RS; Hentges CR; Silveira RC
    Am J Perinatol; 2016 Apr; 33(5):480-5. PubMed ID: 26529476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum surfactant protein D as a marker for bronchopulmonary dysplasia.
    Vinod S; Gow A; Weinberger B; Potak D; Hiatt M; Chandra S; Hegyi T
    J Matern Fetal Neonatal Med; 2019 Mar; 32(5):815-819. PubMed ID: 29025303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
    Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH
    Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia.
    De Felice C; Latini G; Del Vecchio A; Toti P; Bagnoli F; Petraglia F
    Pediatrics; 2002 Aug; 110(2 Pt 1):386-8. PubMed ID: 12165595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants.
    Borghesi A; Massa M; Campanelli R; Garofoli F; Longo S; Cabano R; Mazzucchelli I; Tzialla C; Gavilanes AW; Gazzolo D; Manzoni P; Bollani L; Spinillo A; Rosti V; Stronati M
    Int J Immunopathol Pharmacol; 2013; 26(3):809-16. PubMed ID: 24067483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the level of urinary cysteinyl leukotriene E4 in diagnosis of bronchopulmonary dysplasia in premature infants].
    Jin R; Lu HY; Luo YY; Xu YX; Hu YH; Chen XQ
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):703-7. PubMed ID: 27596087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants.
    Radulova P; Boncheva M; Nachev G; Slancheva B; Dimitrova V
    Crit Care Res Pract; 2024; 2024():3623948. PubMed ID: 38328675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.